Literature DB >> 10394132

Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.

C W Kim1, S H Choi, E J Chung, M J Lee, E K Byun, M H Ryu, Y J Bang.   

Abstract

The mechanisms underlying the impaired immune response frequently observed in cancer patients are not fully understood. Alteration of T-cell-associated signal transduction molecules has recently been implicated in immune suppression in tumor-bearing hosts. Furthermore, T cells from tumor-bearing host, irrespective of the presence of the zeta-chain, showed a lack of proliferative activity and cytotoxic function. In the present study, we investigated the expression of the zeta-chain molecule and the p56(lck) and p59(fyn) protein tyrosine kinase (PTK) levels in peripheral blood T lymphocytes (T-PBL) from patients with advanced gastric carcinomas; for this, flow cytometric analysis and immunoblotting, respectively, were used. We also compared the results of flow cytometric analysis of PBL between stomach cancer patients and normal healthy volunteers. In T-PBL from 22 tumor-bearing hosts, significantly reduced zeta-chain expression (16/22, 73%) was observed. Moreover, the expression level of p56(lck) in T-PBL from patients was significantly lower than that of p59(fyn). Flow cytometric analysis of T-PBL indicated a markedly increased CD8+28- cell population in T-PBL from 19 tumor-bearing hosts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394132     DOI: 10.1159/000028061

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

Review 1.  Fluorescent probe ABM and estimation of immune state in patients with different pathologies (review article).

Authors:  Inta Kalnina; Ruta Bruvere; Tija Zvagule; Natalija Gabruseva; Laura Klimkane; Elena Kirilova; Imants Meirovics; Gunta Kizane
Journal:  J Fluoresc       Date:  2009-08-01       Impact factor: 2.217

2.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

Review 3.  Multifactorial etiology of gastric cancer.

Authors:  Jovanny Zabaleta
Journal:  Methods Mol Biol       Date:  2012

4.  A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis.

Authors:  J Bylund; T Christophe; T Cristophe; F Boulay; A Romero; K Hellstrand; C Dahlgren
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.

Authors:  Harlan P Jones; Yi-Chong Wang; Beau Aldridge; Jay M Weiss
Journal:  Cancer Immun       Date:  2008-02-19

6.  Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression.

Authors:  Agata Kosmaczewska; Dorota Bocko; Lidia Ciszak; Iwona Wlodarska-Polinska; Jan Kornafel; Aleksandra Szteblich; Anna Masternak; Irena Frydecka
Journal:  Pathol Oncol Res       Date:  2011-11-19       Impact factor: 3.201

Review 7.  Pattern-recognition receptors and gastric cancer.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.